Circulating Soluble Vascular Cell Adhesion Molecule-1 and Intercellular Adhesion Molecule-1 in Immunocompetent and Renal Transplant Patients: Correlation with Cytomegalovirus Disease and Renal Function

References

• Cotran RS, Gimbrone MA Jr, Bevilacqua MP, Mendick DL, Pober JS. Induction and detection of a human endothelial activation antigen in vivo. J Exp Med 1986; 164: 661–6.
   PubMed Web of Science ®Google Scholar
• Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL-1 and interferon gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986; 137: 245–54.
   Google Scholar
• Bishop GA, Hall BM. Expression of leucocyte and lymphocyte adhesion molecules in the human kidney. Clin Invest 1989; 36: 1078–85.
   Google Scholar
• Brockmeyer C, Ulbrecht M, Schendel DJ, Weiss EH, Hiller-brand G, Burkhardt K, et al. Distribution of cell adhesion molecules (ICAM-1, VCAM-1, ELAM-1) in renal tissue during allograft rejection. Transplantation 1993; 55: 610–5.
   Google Scholar
• Hill P, Main IW, Atkins RC. ICAM-1 and VCAM-1 in human renal allograft rejection. Kidney Int 1995; 47: 1383–91.
   PubMed Web of Science ®Google Scholar
• Alpers CE, Hudkins KL, Davis CL, Marsh CL, Riches W, McCarty JM, et al. Expression of vascular cell adhesion molecule-1 in kidney allograft rejection. Kidney Int 1993; 44: 805–16.
   PubMed Web of Science ®Google Scholar
• Gearing A, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993; 14: 506–12.
   PubMedGoogle Scholar
• Seth R, Raymond FD, Makgoba MW. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet 1991; 338: 83–4.
   Google Scholar
• Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol 1991; 147: 3788–93.
   PubMed Web of Science ®Google Scholar
• Gruschwitz M, Hornstein O, von den Driesch P. Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity. Arthritis Rheum 1995; 38: 184–9.
   Google Scholar
• Gearing AJH, Hemingway I, Pigott R, Hughes J, Rees AJ, Cashman SJ. Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1 and VCAM-1: pathological significance. Ann NY Acad Sci 1993; 324–31.
   Google Scholar
• Stockenhuber F, Kramer G, Schenn G, Pec M, Keil M, Gnant M, et al. Circulating ICAM-1: novel parameter of renal graft function. Transpl Proc 1993; 25: 919–20.
   PubMedGoogle Scholar
• Adams D, Mainolfi E, Elias E, Neuberger J, Rothlein R. Detection of circulating intercellular adhesion molecule-1 after liver transplantation – evidence of local release within the liver during graft rejection. Transplantation 1993; 55: 83–7.
   Google Scholar
• Alcalde G, Merino J, Sanz S, Zubimendi JA, Ruiz JC, Torrijos J, et al. Circulating adhesion molecules during kidney allograft rejection. Transplantation 1995; 59: 1695–9.
   PubMedGoogle Scholar
• Häyry P, Isoniemi H, Yilmaz S, Mennander A, Lemstrom K, Raisanen-Sokolowski A, et al. Chronic allograft rejection. Immunol Rev 1993; 134: 33–81.
   PubMedGoogle Scholar
• Knight D, Waldman WJ, Sedmak DD. Cytomegalovirus-mediated modulation of adhesion molecule expression by human arterial and microvascular endothelial cells. Transplantation 1999; 68: 1814–8.
   Google Scholar
• Burns LJ, Pooley JC, Walsh DJ, Vercelotti GM, Weber ML, Kovacs A. Intercellular adhesion molecule-1 expression in endothelial cells is activated by cytomegalovirus immediate early proteins. Transplantation 1999; 67: 137–44.
   PubMedGoogle Scholar
• Eriksson B-M, Zweygberg Wirgart B, Claesson K, Tufveson G, Magnusson G, Tötterman TH, Grillner L. A prospective study of rapid methods of detecting cytomegalovirus in the blood of renal transplant recipients in relation to patient and graft survival. Clin Transpl 1996; 10: 494–502.
   Google Scholar
• Hanås E, Larsson E, Fellström B, Lindgren PG, Andersson T, Busch C, et al. Safety aspects and diagnostic findings of renal allograft biopsies, obtained by an automatic technique with a midsize needle. Scand J Urol Nephrol 1992; 26: 413–20.
   Google Scholar
• Grillner L. Screening of blood donors for cytomegalovirus (CMV) antibodies. An evaluation of different tests. J Virol Meth 1987; 17: 133–9.
   PubMed Web of Science ®Google Scholar
• Zweygberg Wirgart B, Hökeberg I, Landqvist M, Grillner L. Detection of cytomegalovirus directly in blood leukocytes and evaluation of a new CMV monoclonal antibody, AAC10. Serodiag Immunother Infect Dis 1990; 4: 419–26.
   Google Scholar
• Dörge S-E, Roux-Lombard P, Dayer J-M, Koch K-M, Frei U, Lonnemann G. Plasma levels of tumor necrosis factor (TNF) and soluble TNF receptors in kidney transplant recipients. Transplantation 1994; 58: 1000–8.
   PubMedGoogle Scholar
• Koskinen PK, Lemstrom KB, Häyry PJ. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts. Am J Pathol 1995; 146: 972.
   Google Scholar
• Koskinen P. The association of the induction of vascular cell adhesion molecule-1 with cytomegalovirus antigenemia in human heart allografts. Transplantation 1993; 56: 1103–8.
   PubMed Web of Science ®Google Scholar
• Lopez C, Simmons RL, Mauer SM, Najarian JS, Good RA. Association of renal allograft rejection with virus infections. Am J Med 1974; 56: 280–9.
   PubMed Web of Science ®Google Scholar
• Pouteil-Noble C, Ecochard R, Landrivon G, Donia-Maged A, Tardy J-C, Bosshard S, et al. Cytomegalovirus infection – an etiological factor for rejection? Transplantation 1993; 55: 851–7.
   Google Scholar
• Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261: 3561&#x20136
   Google Scholar